Data / Form D filings / Paragon Biosciences Emalex Capital, Inc.
Paragon Biosciences Emalex Capital, Inc.: Form D filings
Paragon Biosciences Emalex Capital, Inc., a pharmaceuticals company in Chicaco, IL, filed 10 Form D notices with the SEC between 2018 and 2025. The latest, on July 8, 2025, reports $270 million sold of a $270 million offering to 42 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 303 N WABASH AVE, SUITE # 3500, Chicaco, IL, 60611
- Phone
- (847) 715-0606
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1749990
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | Amendment | $270,000,000 | $270,000,000 | 42 | May 18, 2022 | sec.gov | |
| Mar 25, 2025 | Amendment | $242,000,000 | $217,000,000 | $25,000,000 | 42 | May 18, 2022 | sec.gov |
| Nov 10, 2022 | Amendment | $250,000,000 | $185,000,000 | $65,000,000 | 42 | Oct 21, 2022 | sec.gov |
| Nov 4, 2022 | New notice | $250,000,000 | $185,000,000 | $65,000,000 | 42 | Oct 21, 2022 | sec.gov |
| Nov 4, 2022 | New notice | $25,000,000 | $25,000,000 | 35 | May 18, 2022 | sec.gov | |
| Mar 12, 2021 | Amendment | $35,000,010 | $35,000,010 | 21 | Feb 25, 2021 | sec.gov | |
| Mar 12, 2021 | New notice | $35,000,010 | $35,000,010 | 21 | Feb 25, 2021 | sec.gov | |
| Oct 3, 2019 | New notice | $37,423,356 | $37,423,356 | 10 | Sep 18, 2019 | sec.gov | |
| Dec 7, 2018 | Amendment | $9,375,000 | $9,375,000 | 31 | Jul 31, 2018 | sec.gov | |
| Aug 14, 2018 | New notice | $6,925,000 | $6,925,000 | 15 | Jul 31, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick J. Morris | Executive Officer | |
| Jeffrey J. Aronin | Director | |
| Antonio J. Gracias | Director | |
| Eric J. Messner | Executive Officer, Director | |
| Ricky J. Sun | Director | |
| Jeffrey J. Dayno | Director | |
| Darien J. Parhad | Executive Officer |
Every Form D from the week of Jul 7, 2025 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Paragon Biosciences Emalex Capital, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.